Not All Hepatocellular Carcinoma Patients with Microvascular Invasion After R0 Resection Could Be Benefited from Prophylactic Transarterial Chemoembolization: A Propensity Score Matching Study.

Lei WangQiao KeKongying LinJingbo ChenRen WangChunhong XiaoXiaolong LiuJingfeng Liu

Published in: Cancer management and research (2020)

With the current data, we concluded that not all HCC patients with MVI would be benefited from p-TACE, and p-TACE could benefit patients with "middle risk" according to the current staging systems.

Keyphrases

radiofrequency ablation
lymph node
electronic health record
cell migration
big data
machine learning
liver metastases
artificial intelligence
deep learning